Q32 Bio (QTTB) Total Debt (2023 - 2026)

Q32 Bio (QTTB) recorded quarterly Total Debt of $8.2 million in Q1 2026, down 15.76% quarter-over-quarter from $9.7 million in Q4 2025, and down 35.61% on a YoY basis from $12.7 million in Q1 2025.

Q32 Bio (QTTB) Total Debt (2023 - 2026) Analysis & Trends

Q32 Bio's Total Debt history runs 4 years deep, the most recent figure standing at $8.2 million for Q1 2026.

  • In Q1 2026, Total Debt fell 35.61% year-over-year to $8.2 million; the TTM figure through Mar 2026 stood at $8.2 million (down 35.61% YoY), while the FY2025 annual figure was $9.7 million, down 23.28% from the prior year.
  • Total Debt was $8.2 million for Q1 2026 at Q32 Bio, down from $9.7 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $12.8 million in Q2 2025 to a low of $5.5 million in Q4 2023.
  • Historically, Total Debt has averaged $11.0 million across 4 years, with a median of $12.5 million in 2024.
  • The sharpest annual moves came in 2024 and 2026: Total Debt soared 131.78% in 2024, then plunged 35.61% in 2026.
  • A 4-year view of Total Debt shows it stood at $5.5 million in 2023, then jumped by 131.78% to $12.7 million in 2024, then fell by 23.28% to $9.7 million in 2025, then decreased by 15.76% to $8.2 million in 2026.
  • The last three Total Debt figures came in at $8.2 million (Q1 2026), $9.7 million (Q4 2025), and $11.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 319.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Q32 Bio 167.59 Mn 116.84 Mn - 8.18 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.18 Mn
Dec 31, 2025 9.71 Mn
Sep 30, 2025 11.23 Mn
Jun 30, 2025 12.75 Mn
Mar 31, 2025 12.70 Mn
Dec 31, 2024 12.65 Mn
Sep 30, 2024 12.60 Mn
Jun 30, 2024 12.55 Mn
Mar 31, 2024 12.49 Mn
Dec 31, 2023 5.46 Mn